A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. [electronic resource]
Producer: 20150109Description: 41-8 p. digitalISSN:- 1873-7064
- Animals
- Central Nervous System Agents -- pharmacology
- Enzyme Inhibitors -- pharmacology
- Glutamic Acid -- metabolism
- Kynurenic Acid -- metabolism
- Kynurenine -- pharmacology
- Male
- Membrane Potentials -- drug effects
- Microdialysis
- Microelectrodes
- Nicotine -- pharmacology
- Nicotinic Agonists -- pharmacology
- Potassium Chloride -- pharmacology
- Prefrontal Cortex -- drug effects
- Pyrazoles -- pharmacology
- Rats, Sprague-Dawley
- Rats, Wistar
- Transaminases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.